Publication Date

4-2025

Files

Download

Download Full Text (702 KB)

Abstract

The COVID-19 pandemic drastically altered the way clinical research is conducted through a widespread adoption of telemedicine practices to continue clinical trial procedures during peak periods of global COVID-19 spread. Using telehealth/telemedicine services allows researchers to conduct “decentralized clinical trials”, or DCTs, for all or portions of study protocol procedures while maintaining safety measures implemented for pandemic control. However, research sites are hesitant to adopt DCT policies due to concerns around digital health technology, data safety and quality, and limited information in the literature specifically assessing telemedicine use for pediatric clinical research via DCTs or how equipped pediatric research sites are for the transition away from the site. A cross-sectional, observational casestudy surveying clinical research professionals (CRPs) at a local pediatric institution in Kansas City, MO, was conducted to better understand pediatric site facilitators and barriers to implementation and utilization of DCTs from a site perspective.

Disciplines

Pediatrics

Notes

Presented at the Association of Clinical Research Professionals (ACRP) 2025; New Orleans, LA; April 24-27, 2025.

Facilitators, Barriers, & Recommendations for Pediatric Research Sites Conducting Decentralized Clinical Trials (DCTs)

Included in

Pediatrics Commons

Share

COinS